Logo image of TLYS

TILLY'S INC-CLASS A SHRS (TLYS) Stock Fundamental Analysis

NYSE:TLYS - New York Stock Exchange, Inc. - US8868851028 - Common Stock - Currency: USD

1.28  0 (0%)

Premarket: 1.22 -0.06 (-4.69%)

Fundamental Rating

2

Taking everything into account, TLYS scores 2 out of 10 in our fundamental rating. TLYS was compared to 120 industry peers in the Specialty Retail industry. The financial health of TLYS is average, but there are quite some concerns on its profitability. TLYS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TLYS had negative earnings in the past year.
TLYS had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: TLYS reported negative net income in multiple years.
In multiple years TLYS reported negative operating cash flow during the last 5 years.
TLYS Yearly Net Income VS EBIT VS OCF VS FCFTLYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

TLYS has a worse Return On Assets (-14.59%) than 82.50% of its industry peers.
TLYS has a Return On Equity of -61.63%. This is in the lower half of the industry: TLYS underperforms 73.33% of its industry peers.
Industry RankSector Rank
ROA -14.59%
ROE -61.63%
ROIC N/A
ROA(3y)-6.5%
ROA(5y)-1.4%
ROE(3y)-21.38%
ROE(5y)-5.62%
ROIC(3y)N/A
ROIC(5y)N/A
TLYS Yearly ROA, ROE, ROICTLYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

TLYS has a worse Gross Margin (26.13%) than 73.33% of its industry peers.
TLYS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for TLYS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.67%
GM growth 5Y-2.7%
TLYS Yearly Profit, Operating, Gross MarginsTLYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

TLYS does not have a ROIC to compare to the WACC, probably because it is not profitable.
TLYS has more shares outstanding than it did 1 year ago.
TLYS has more shares outstanding than it did 5 years ago.
There is no outstanding debt for TLYS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TLYS Yearly Shares OutstandingTLYS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
TLYS Yearly Total Debt VS Total AssetsTLYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

TLYS has an Altman-Z score of 0.93. This is a bad value and indicates that TLYS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of TLYS (0.93) is worse than 73.33% of its industry peers.
TLYS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.93
ROIC/WACCN/A
WACC9.66%
TLYS Yearly LT Debt VS Equity VS FCFTLYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

TLYS has a Current Ratio of 1.09. This is a normal value and indicates that TLYS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.09, TLYS is not doing good in the industry: 69.17% of the companies in the same industry are doing better.
TLYS has a Quick Ratio of 1.09. This is a bad value and indicates that TLYS is not financially healthy enough and could expect problems in meeting its short term obligations.
TLYS's Quick ratio of 0.44 is in line compared to the rest of the industry. TLYS outperforms 43.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.44
TLYS Yearly Current Assets VS Current LiabilitesTLYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for TLYS have decreased strongly by -81.80% in the last year.
TLYS shows a decrease in Revenue. In the last year, the revenue decreased by -8.80%.
Measured over the past years, TLYS shows a decrease in Revenue. The Revenue has been decreasing by -1.66% on average per year.
EPS 1Y (TTM)-81.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.85%
Revenue 1Y (TTM)-8.8%
Revenue growth 3Y-9.79%
Revenue growth 5Y-1.66%
Sales Q2Q%-7.12%

3.2 Future

The Earnings Per Share is expected to grow by 26.97% on average over the next years. This is a very strong growth
Based on estimates for the next years, TLYS will show a small growth in Revenue. The Revenue will grow by 2.04% on average per year.
EPS Next Y17.56%
EPS Next 2Y24.34%
EPS Next 3Y26.97%
EPS Next 5YN/A
Revenue Next Year-5.31%
Revenue Next 2Y-0.19%
Revenue Next 3Y2.04%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TLYS Yearly Revenue VS EstimatesTLYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
TLYS Yearly EPS VS EstimatesTLYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TLYS. In the last year negative earnings were reported.
Also next year TLYS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLYS Price Earnings VS Forward Price EarningsTLYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TLYS Per share dataTLYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

TLYS's earnings are expected to grow with 26.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.34%
EPS Next 3Y26.97%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TLYS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TILLY'S INC-CLASS A SHRS

NYSE:TLYS (6/10/2025, 8:12:17 PM)

Premarket: 1.22 -0.06 (-4.69%)

1.28

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)06-04 2025-06-04/amc
Earnings (Next)09-03 2025-09-03/amc
Inst Owners98.15%
Inst Owner Change1.8%
Ins Owners1.96%
Ins Owner Change40.51%
Market Cap38.59M
Analysts45.71
Price Target2.55 (99.22%)
Short Float %7.3%
Short Ratio3.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.74%
Min EPS beat(2)-49.55%
Max EPS beat(2)-9.92%
EPS beat(4)1
Avg EPS beat(4)6.78%
Min EPS beat(4)-49.55%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)19.27%
EPS beat(12)6
Avg EPS beat(12)58.54%
EPS beat(16)9
Avg EPS beat(16)52.21%
Revenue beat(2)0
Avg Revenue beat(2)-6.1%
Min Revenue beat(2)-9.69%
Max Revenue beat(2)-2.5%
Revenue beat(4)0
Avg Revenue beat(4)-3.72%
Min Revenue beat(4)-9.69%
Max Revenue beat(4)-0.14%
Revenue beat(8)1
Avg Revenue beat(8)-2.09%
Revenue beat(12)2
Avg Revenue beat(12)-1.73%
Revenue beat(16)4
Avg Revenue beat(16)-0.83%
PT rev (1m)0%
PT rev (3m)-50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-53.49%
EPS NY rev (1m)0%
EPS NY rev (3m)-90%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.49
EV/EBITDA N/A
EPS(TTM)-1.62
EYN/A
EPS(NY)-0.69
Fwd EYN/A
FCF(TTM)-1.06
FCFYN/A
OCF(TTM)-0.81
OCFYN/A
SpS18.61
BVpS2.62
TBVpS2.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.59%
ROE -61.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.13%
FCFM N/A
ROA(3y)-6.5%
ROA(5y)-1.4%
ROE(3y)-21.38%
ROE(5y)-5.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.67%
GM growth 5Y-2.7%
F-Score3
Asset Turnover1.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 60.85%
Cap/Sales 1.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.44
Altman-Z 0.93
F-Score3
WACC9.66%
ROIC/WACCN/A
Cap/Depr(3y)93.39%
Cap/Depr(5y)80.87%
Cap/Sales(3y)1.98%
Cap/Sales(5y)1.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.85%
EPS Next Y17.56%
EPS Next 2Y24.34%
EPS Next 3Y26.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.8%
Revenue growth 3Y-9.79%
Revenue growth 5Y-1.66%
Sales Q2Q%-7.12%
Revenue Next Year-5.31%
Revenue Next 2Y-0.19%
Revenue Next 3Y2.04%
Revenue Next 5YN/A
EBIT growth 1Y-62.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.88%
EBIT Next 3Y32.43%
EBIT Next 5YN/A
FCF growth 1Y-90.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34824.3%
OCF growth 3YN/A
OCF growth 5YN/A